Paragraf Direct Growth Advantage
Paragraf
The manufacturing method is the moat here, because graphene sensors fail or drift when the atom thin film is damaged or contaminated before it ever reaches the customer. Paragraf grows graphene directly on the target wafer with a transfer free, metal free process, while Graphenea sells transferred graphene wafers and transfer services. In practice, every transfer step adds chances for cracks, wrinkles, residue, and metal contamination, which lowers the share of chips on a wafer that behave the same way in production.
-
Graphenea’s business is built around transferred material. It sells graphene on SiO2/Si, quartz, PET, and other substrates, plus an Easy Transfer product and custom transfer service. That is flexible for R&D users, but it means the graphene is moved from where it was grown to where the device is built.
-
Paragraf’s process is designed to remove that handoff. The company says it grows monolayer graphene directly on semiconductor wafers, first on 2 inch sapphire and now on 6 inch silicon, using standard semiconductor tooling. That matters because device makers want wafers that can go straight into normal fab, packaging, and test flows.
-
This difference shows up most in biosensors and GFETs, where one bad patch of graphene can throw off the electrical signal from a liquid sample. Graphenea is well positioned as a foundry and materials supplier for experimentation, while Paragraf is aiming at tighter process control for repeatable commercial devices.
As graphene moves from lab prototypes into diagnostic cartridges and semiconductor scale production, direct growth should become more valuable than raw material availability alone. The winners are likely to be the companies that can deliver not just sensitive graphene devices, but wafers whose electrical behavior is uniform enough for high volume packaging, calibration, and field reliability.